The roles of glucose metabolic reprogramming in chemo- and radio-resistance

被引:133
作者
Lin, Jinguan [1 ,2 ]
Xia, Longzheng [1 ,2 ]
Liang, Jiaxin [1 ,2 ]
Han, Yaqian [1 ,2 ]
Wang, Heran [1 ,2 ]
Oyang, Linda [1 ,2 ]
Tan, Shiming [1 ,2 ]
Tian, Yutong [1 ,2 ]
Rao, Shan [1 ,2 ]
Chen, Xiaoyan [1 ,2 ]
Tang, Yanyan [1 ,2 ]
Su, Min [1 ,2 ]
Luo, Xia [1 ,2 ]
Wang, Ying [1 ,2 ]
Wang, Hui [1 ,2 ]
Zhou, Yujuan [1 ,2 ]
Liao, Qianjin [1 ,2 ]
机构
[1] Cent South Univ, Xiangya Sch Med, Affiliated Canc Hosp, 283 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China
[2] Hunan Canc Hosp, Key Lab Translat Radiat Oncol, 283 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China
基金
中国国家自然科学基金;
关键词
Metabolic reprogramming; Chemo-resistance; Radio-resistance; TME; BLADDER-CANCER CELLS; OXIDATIVE STRESS; PROSTATE-CANCER; EXTRACELLULAR VESICLES; THERAPEUTIC STRATEGIES; AEROBIC GLYCOLYSIS; DRUG-RESISTANCE; OVARIAN-CANCER; TUMOR-GROWTH; DNA-REPAIR;
D O I
10.1186/s13046-019-1214-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Reprogramming of cancer metabolism is a newly recognized hallmark of malignancy. The aberrant glucose metabolism is associated with dramatically increased bioenergetics, biosynthetic, and redox demands, which is vital to maintain rapid cell proliferation, tumor progression, and resistance to chemotherapy and radiation. When the glucose metabolism of cancer is rewiring, the characters of cancer will also occur corresponding changes to regulate the chemo- and radio-resistance of cancer. The procedure is involved in the alteration of many activities, such as the aberrant DNA repairing, enhanced autophagy, oxygen-deficient environment, and increasing exosomes secretions, etc. Targeting altered metabolic pathways related with the glucose metabolism has become a promising anti-cancer strategy. This review summarizes recent progress in our understanding of glucose metabolism in chemo- and radio-resistance malignancy, and highlights potential molecular targets and their inhibitors for cancer treatment.
引用
收藏
页数:13
相关论文
共 187 条
[1]   Mechanisms of chemoresistance in cancer stem cells [J].
Abdullah, Lissa Nurrul ;
Chow, Edward Kai-Hua .
CLINICAL AND TRANSLATIONAL MEDICINE, 2013, 2
[2]   Metabolic coupling in urothelial bladder cancer compartments and its correlation to tumor aggressiveness [J].
Afonso, Julieta ;
Santos, Lucio L. ;
Morais, Antonio ;
Amaro, Teresina ;
Longatto-Filho, Adhemar ;
Baltazar, Fatima .
CELL CYCLE, 2016, 15 (03) :368-380
[3]  
Agarwal Saurabh, 2018, Oncotarget, V9, P30024, DOI 10.18632/oncotarget.25776
[4]  
Agarwal Saurabh, 2018, Oncotarget, V9, P20323, DOI 10.18632/oncotarget.24859
[5]   Aggressive serous epithelial ovarian cancer is potentially propagated by EpCAM+CD45+ phenotype [J].
Akhter, Md Zahid ;
Sharawat, Surender K. ;
Kumar, Vikash ;
Kochat, Veena ;
Equbal, Zaffar ;
Ramakrishnan, Mallika ;
Kumar, Umesh ;
Mathur, Sandeep ;
Kumar, Lalit ;
Mukhopadhyay, Asok .
ONCOGENE, 2018, 37 (16) :2089-2103
[6]   The Combination of Rapamycin and Resveratrol Blocks Autophagy and Induces Apoptosis in Breast Cancer Cells [J].
Alayev, Anya ;
Berger, Sara Malka ;
Kramer, Melissa Y. ;
Schwartz, Naomi S. ;
Holz, Marina K. .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2015, 116 (03) :450-457
[7]   Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate [J].
Andronesi, Ovidiu C. ;
Arrillaga-Romany, Isabel C. ;
Ly, K. Ina ;
Bogner, Wolfgang ;
Ratai, Eva M. ;
Reitz, Kara ;
Iafrate, A. John ;
Dietrich, Jorg ;
Gerstner, Elizabeth R. ;
Chi, Andrew S. ;
Rosen, Bruce R. ;
Wen, Patrick Y. ;
Cahill, Daniel P. ;
Batchelor, Tracy T. .
NATURE COMMUNICATIONS, 2018, 9
[8]   A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells [J].
Barsoum, Ivraym B. ;
Smallwood, Chelsea A. ;
Siemens, D. Robert ;
Graham, Charles H. .
CANCER RESEARCH, 2014, 74 (03) :665-674
[9]   Targeting the microenvironment in solid tumors [J].
Belli, Carmen ;
Trapani, Dario ;
Viale, Giulia ;
D'Amico, Paolo ;
Duso, Bruno Achutti ;
Della Vigna, Paolo ;
Orsi, Franco ;
Curigliano, Giuseppe .
CANCER TREATMENT REVIEWS, 2018, 65 :22-32
[10]   Synergy between the KEAP1/NRF2 and PI3K Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune Microenvironment [J].
Best, Sarah A. ;
De Souza, David P. ;
Kersbergen, Ariena ;
Policheni, Antonia N. ;
Dayalan, Saravanan ;
Tull, Dedreia ;
Rathi, Vivek ;
Gray, Daniel H. ;
Ritchie, Matthew E. ;
McConville, Malcolm J. ;
Sutherland, Kate D. .
CELL METABOLISM, 2018, 27 (04) :935-+